Facebook
Twitter
LinkedIn
Forward
Symptom burden is high in thoracic surgery and oncology patients. Gita Mody, MD, MPH discusses the role of electronic patient-reported outcome (ePRO) remote monitoring systems to improve patients' survivorship care.
|
William Wood, MD, MPH will review ways to expand traditional clinic-based cancer navigation to population-based cancer navigation using a central navigation approach. We will discuss how this approach can foster equity in care delivery and outcomes, while incorporating new initiatives that promote quality improvement. We will also talk about how this work fits into the current national environment that surrounds cancer navigation, including the recent development of a learning community and of new proposed billing codes that support the delivery of navigation services.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will provide a general overview of Prostate Cancer. The audience will learn about basic pathophysiology and epidemiology as it relates to both local and advanced disease. This course will then provide insight into the pros & cons of prostate cancer screening as well as the accepted diagnostic procedures & scoring.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will go into more detail for treatment options and considerations for treating localized prostate cancer and the management of side effects.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will discuss the different treatment options for advanced prostate cancer as well as considerations for management side effects and maximizing a survivor’s quality of life.
|
Allison Phillips, MPAP, MHPE, PA-C, reviews the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH.
|
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.
|
Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.
|
Marc Bjurlin, DO, MSc, FACOS, gives a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.
|
Puneet Singh Jolly, MD, PhD discusses keratinocyte neoplasms are by far the most common malignancy in the world. While surgical treatments remain the most common and most effective therapy, there are numerous emerging non-surgical techniques. We discuss these and the rationale for using such treatments, particularly in specific challenging clinical scenarios.
|